Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids

Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids Incorporation of histone deacetylase inhibitory activity into the core of tamoxifen – A new hybrid design paradigm Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids Synthesis of hybrid anticancer agents based on kinase and histone deacetylase inhibitors Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitors Antiproliferative and Differentiating Activities of a Novel Series of Histone Deacetylase Inhibitors Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy